Comparison of direct health care costs related to the pharmacological treatment of osteoporosis and to the management of osteoporotic fractures among compliant and noncompliant users of alendronate and risedronate: A population-based study

Osteoporosis International

Volumn 20, Issue 9, 2009, Pages 1571-1581

  Blouin, J ^a   Dragomir, A ^a   Fredette, M ^b   Ste Marie, L G ^a   Fernandes, J C ^a   Perreault, S ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b HEC MONTRÉAL   (Canada)

Author keywords

Alendronate; Direct health care costs; Noncompliance; Risedronate

Indexed keywords

ALENDRONIC ACID; RISEDRONIC ACID;

AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG COST; FEMALE; FOLLOW UP; FRAGILITY FRACTURE; HEALTH CARE COST; HOSPITAL COST; HUMAN; MAJOR CLINICAL STUDY; MEDICAL FEE; OSTEOPOROSIS; PATIENT COMPLIANCE; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL;

AGED; ALENDRONATE; BONE DENSITY CONSERVATION AGENTS; CONFIDENCE INTERVALS; ETIDRONIC ACID; FEMALE; FRACTURES, BONE; HEALTH CARE COSTS; HUMANS; MALE; OSTEOPOROSIS; RISK FACTORS;

EID: 68949220425     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-008-0818-5     Document Type: Article

References (32)

1. JA Udell MA Fischer MA Brookhart DH Solomon NK Choudhry 2006 Effect of the Women's Health Initiative on osteoporosis therapy and expenditure in Medicaid J Bone Miner Res 21 5 765 771
2. JA Cramer DT Gold SL Silverman EM Lewiecki 2007 A systematic review of persistence and compliance with bisphosphonates for osteoporosis Osteoporos Int 18 8 1023 1031
3. J Blouin A Dragomir LG Ste-Marie JC Fernandes S Perreault 2007 Discontinuation of antiresorptive therapies: a comparison between 1998-2001 and 2002-2004 among osteoporotic women J Clin Endocrinol Metab 92 3 887 894
4. ES Siris ST Harris CJ Rosen CE Barr JN Arvesen TA Abbott S Silverman 2006 Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases Mayo Clin Proc 81 8 1013 1022
5. FJ Penning-van Beest JA Erkens M Olson RM Herings 2007 Loss of treatment benefit due to low compliance with bisphosphonate therapy Osteoporos Int 19 4 511 517
6. J Blouin A Dragomir Y Moride LG Ste-Marie JC Fernandes S Perreault 2008 Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women Br J Clin Pharmacol 66 1 117 127
7. BA Briesacher SE Andrade RA Yood KH Kahler 2007 Consequences of poor compliance with bisphosphonates Bone 41 5 882 887
8. AV Schwartz DE Sellmeyer KE Ensrud JA Cauley HK Tabor PJ Schreiner SA Jamal DM Black SR Cummings 2001 Older women with diabetes have an increased risk of fracture: a prospective study J Clin Endocrinol Metab 86 1 32 38
9. U Sennerby B Farahmand A Ahlbom S Ljunghall K Michaelsson 2007 Cardiovascular diseases and future risk of hip fracture in women Osteoporos Int 18 10 1355 1362
10. J Huopio R Honkanen J Jurvelin S Saarikoski E Alhava H Kroger 2005 Role of chronic health disorders in perimenopausal fractures Osteoporos Int 16 11 1404 1411
11. E Akobundu J Ju L Blatt CD Mullins 2006 Cost-of-illness studies: a review of current methods Pharmacoeconomics 24 9 869 890
12. LS Orsini MD Rousculp SR Long S Wang 2005 Health care utilization and expenditures in the United States: a study of osteoporosis-related fractures Osteoporos Int 16 4 359 371
13. Government of Quebec (2004) Régie de l'assurance maladie du Québec. Rapport annuel de gestion 2003-2004. pp 113-119
14. R Tamblyn G Lavoie L Petrella J Monette 1995 The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec J Clin Epidemiol 48 8 999 1009
15. C Gennari 2002 Analgesic effect of calcitonin in osteoporosis Bone 30 5 Suppl 67S 70S
16. AM Peterson DP Nau JA Cramer J Benner F Gwadry-Sridhar M Nichol 2007 A checklist for medication compliance and persistence studies using retrospective databases Value Health 10 1 3 12
17. R Sikka F Xia RE Aubert 2005 Estimating medication persistency using administrative claims data Am J Manag Care 11 7 449 457
18. JJ Caro KJ Ishak KF Huybrechts G Raggio C Naujoks 2004 The impact of compliance with osteoporosis therapy on fracture rates in actual practice Osteoporos Int 15 12 1003 1008
19. KF Huybrechts KJ Ishak JJ Caro 2006 Assessment of compliance with osteoporosis treatment and its consequences in a managed care population Bone 38 6 922 928
20. R Tamblyn T Reid N Mayo P McLeod M Churchill-Smith 2000 Using medical services claims to assess injuries in the elderly: sensitivity of diagnostic and procedure codes for injury ascertainment J Clin Epidemiol 53 2 183 194
21. M Von Korff EH Wagner K Saunders 1992 A chronic disease score from automated pharmacy data J Clin Epidemiol 45 2 197 203
22. KG Putnam DS Buist P Fishman SE Andrade M Boles GA Chase MJ Goodman JH Gurwitz R Platt MA Raebel CK Arnold 2002 Chronic disease score as a predictor of hospitalization Epidemiology 13 3 340 346
23. AJ Perkins K Kroenke J Unutzer W Katon JW Williams C Hope CM Callahan 2004 Common comorbidity scales were similar in their ability to predict health care costs and mortality J Clin Epidemiol 57 10 1040 1048
24. JA Grisso JL Kelsey BL Strom GY Chiu G Maislin LA O'Brien S Hoffman F Kaplan 1991 Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study Group N Engl J Med 324 19 1326 1331
25. AA Afifi JB Kotlerman SL Ettner M Cowan 2007 Methods for improving regression analysis for skewed continuous or counted responses Annu Rev Public Health 28 95 111
26. WG Manning 1998 The logged dependent variable, heteroscedasticity, and the retransformation problem J Health Econ 17 3 283 295
27. WG Manning J Mullahy 2001 Estimating log models: to transform or not to transform? J Health Econ 20 4 461 494
28. JS Haukoos RJ Lewis 2005 Advanced statistics: bootstrapping confidence intervals for statistics with "difficult" distributions Acad Emerg Med 12 4 360 365
29. KL Hepke MT Martus DA Share 2004 Costs and utilization associated with pharmaceutical adherence in a diabetic population Am J Manag Care 10 2 Pt 2 144 151
30. MC Sokol KA McGuigan RR Verbrugge RS Epstein 2005 Impact of medication adherence on hospitalization risk and healthcare cost Med Care 43 6 521 530
31. SL West DA Savitz G Koch BL Strom HA Guess A Hartzema 1995 Recall accuracy for prescription medications: self-report compared with database information Am J Epidemiol 142 10 1103 1112
32. M Cree CL Soskolne E Belseck J Hornig JE McElhaney R Brant M Suarez-Almazor 2000 Mortality and institutionalization following hip fracture J Am Geriatr Soc 48 3 283 288